Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSIF.L Regulatory News (SSIF)

  • There is currently no data for SSIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

B Share Scheme and Delisting

29 Jun 2023 07:00

RNS Number : 2867E
Secured Income Fund PLC
29 June 2023
 

Secured Income Fund Plc

LEI: 213800TR2S2TT6PKVH57

29 June 2023

SECURED INCOME FUND PLC

(the "Company")

B Share Scheme and Delisting

Pursuant to the authority received from shareholders at the general meeting held on 23 March 2021, the Board has resolved to return £3,159,621 to Shareholders via a seventh Return of Capital by the issue of B Shares.

B Shares of £1 each will be paid up from capital and issued to all Shareholders by way of a bonus issue pro-rata to their holding of Ordinary Shares on the basis of one B Share for approximately every 16.66 Ordinary Shares held at the Record Date of 6.00 p.m. on 6 July 2023. The B Shares will be issued on 7 July 2023 and immediately redeemed at £1 per B Share. The Redemption Date in respect of this Return of Capital is 7 July 2023. The proceeds from the redemption of the B Shares, which is equivalent to 6.0 pence per Ordinary Share, will be sent to uncertificated Shareholders through CREST or via cheque to certificated Shareholders.

Timetable

It is expected that the timetable will be as follows:

Record date of seventh Return of Capital

6.00 p.m. on 6 July 2023

Ex-date in respect of seventh Return of Capital

7 July 2023

Redemption date of seventh Return of Capital

7 July 2023

Dispatch of cheques in respect of certificated holders

14 July 2023

Uncertificated holders credited with cash proceeds

Pay date for B Share return of capital

17 July 2023

17 July 2023

All redemption payments will be paid gross of tax.

Following the issue and redemption of B shares on 7 July 2023, the total number of Ordinary Shares in issue will remain at 52,660,350 and the total number of voting rights in the Company is 52,660,350. There are no shares held in treasury.

The above figure of 52,660,350 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Delisting

At an extra ordinary general meeting held on 16 December 2021, shareholders in the Company voted in favour of the resolution to delist the Company from the Specialist Funds Segment of the London Stock Exchange once the net assets of the Company fell below £7,000,000. This threshold will be crossed on the ex-date for the seventh Return of Capital on 7 July 2023. The Company therefore proposes to delist from the Specialist Fund Segment of the London Stock Exchange effective 4 August 2023.

The principal effects of the delisting are:

1. There will be no public market on any recognised investment exchange or multilateral trading facility for the Ordinary Shares and, consequently, there can be no guarantee that a Shareholder will be able to purchase or sell any Ordinary Shares;

 

2. While the Ordinary Shares will remain freely transferable, it is likely that the liquidity and marketability of the Ordinary Shares will, in the future, be more constrained than at present and the secondary market value of such Ordinary Shares may be adversely affected as a consequence;

 

3. In the absence of a formal market, it may be more difficult for shareholders to determine the market value of their investment in the Company at any given time;

 

4. The corporate governance, regulatory and financial reporting regime which applies to companies whose shares are admitted to trading on the Specialist Fund Segment will no longer apply;

 

5. There may be taxation consequences for Shareholders as a result of the Shares no longer being admitted to trading on the Specialist Fund Segment. Shareholders should consult their own professional advisers and seek their own advice in connection with the potential consequences of the Cancellation of Trading, including any potential changes in the tax treatment of their holding of Shares; and

 

6. Following the Cancellation of Trading, the Company will cease to be treated as an investment trust with effect from the start of the accounting period in which the Cancellation of Trading occurs. The Directors therefore expect that the Company will cease to be treated as an investment trust for the accounting period which begins on 1 July 2023. As a result of no longer being an investment trust the Company will continue to be liable to UK corporation tax on its profits after deducting allowable expenses. Any gain on the realisation of the investment portfolio above its value on the date prior to the Company losing investment trust status will also be subject to UK corporation tax.

 

The Company will remain registered with the Registrar of Companies in England & Wales in accordance with and subject to the Companies Act 2006, notwithstanding the Cancellation. Shareholders should also note that the Takeover Code will continue to apply to the Company following the Cancellation for a period of 10 years from the date of Cancellation.

The Company will also continue to be bound by its Articles of Association (which require shareholder approval for certain matters) following the Cancellation.

 

Shareholders should be aware that if the Cancellation takes effect, they will at that time cease to hold shares in a quoted company and will become Shareholders in an unquoted company which will be likely significantly to reduce the marketability and liquidity of the Ordinary Shares and the principal effects referred to above will automatically apply to the Company from the date of the Cancellation.

The above considerations are not exhaustive, and Shareholders should seek their own independent advice when assessing the likely impact of the Cancellation on them.

Portfolio Update

 

At 31 May 2023, the Company's investment portfolio comprised ten direct loans with a total carrying value of £5.3 million. The legacy loans across the three remaining borrowers are fully impaired under IFRS 9 and therefore have zero carrying value assigned to them.

 

It is anticipated that the completion of the managed wind-down will take approximately 12 to 18 months. The Directors remain focussed on the realisation of the Company's remaining assets pursuant to the Company's objective of delivering investors total proceeds as close to NAV as possible. B share distributions will continue to be made as and when there are sufficient proceeds.

 

For further announcements regarding the delisting, please visit the website http://www.securedincomefundplc.co.uk/delisting, where you will also be able to register for email updates.

 

For further information please contact:

 

Directors

David Stevenson (Chair)

Susan Gaynor Coley

Brett Miller

 

 

 

tel: +44 7973 873785

tel: +44 7977 130673

tel: +44 7770 447338

 

 

finnCap Ltd.

Corporate Finance: William Marle

Sales: Mark Whitfeld

tel: +44 20 7220 0500

 

(http://www.securedincomefundplc.co.uk/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEVLFLXQLEBBK
Date   Source Headline
2nd Aug 20238:19 amRNSDirector/PDMR Shareholding
1st Aug 202310:59 amRNSDirector/PDMR Shareholding
27th Jul 202312:00 pmRNSHolding(s) in Company
27th Jul 20239:45 amRNSDirector/PDMR Shareholding
25th Jul 202312:54 pmRNSNet Asset Value(s)
29th Jun 20237:00 amRNSB Share Scheme and Delisting
23rd Jun 20237:00 amRNSNet Asset Value(s)
30th May 20237:00 amRNSNet Asset Value(s)
22nd May 20234:45 pmRNSHolding(s) in Company
27th Apr 20237:00 amRNSNet Asset Value(s)
29th Mar 20234:35 pmRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNSNet Asset Value(s)
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20237:00 amRNSHalf-year Report
15th Mar 202310:45 amRNSCancellation of Capital Redemption Reserve
13th Mar 20232:05 pmRNSSecond Price Monitoring Extn
13th Mar 20232:00 pmRNSPrice Monitoring Extension
8th Mar 20232:05 pmRNSSecond Price Monitoring Extn
8th Mar 20232:00 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSNet Asset Value(s)
30th Jan 20239:21 amRNSNet Asset Value(s)
29th Dec 20228:18 amRNSNet Asset Value(s)
15th Dec 20223:51 pmRNSResult of AGM and GM
6th Dec 20225:39 pmRNSHolding(s) in Company
29th Nov 20228:36 amRNSNet Asset Value(s)
23rd Nov 20225:27 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSPublication of a circular
15th Nov 20227:00 amRNSNet Asset Value(s)
9th Nov 20221:24 pmRNSB Share Scheme
27th Sep 20228:48 amRNSNet Asset Value(s)
8th Sep 20224:00 pmRNSHolding(s) in Company
8th Sep 202210:00 amRNSAnnual Financial Report
2nd Sep 202212:00 pmRNSDividend Declaration
25th Aug 202210:00 amRNSNet Asset Value(s)
22nd Jul 20229:30 amRNSNet Asset Value(s)
11th Jul 20222:06 pmRNSSecond Price Monitoring Extn
11th Jul 20222:00 pmRNSPrice Monitoring Extension
11th Jul 202211:05 amRNSSecond Price Monitoring Extn
11th Jul 202211:00 amRNSPrice Monitoring Extension
29th Jun 20229:00 amRNSNet Asset Value(s)
6th Jun 20224:40 pmRNSSecond Price Monitoring Extn
6th Jun 20224:35 pmRNSPrice Monitoring Extension
6th Jun 20229:06 amRNSSecond Price Monitoring Extn
6th Jun 20229:00 amRNSPrice Monitoring Extension
26th May 20223:30 pmRNSB Share Scheme - Amendment
25th May 20224:53 pmRNSB Share Scheme
25th May 20229:00 amRNSNet Asset Value(s)
5th May 202212:00 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.